The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its experimental vaccine targeting six strains of influenza virus. The vaccine candidate, FluMos-v2, is designed to offer protection against four strains of the influenza A…

Read Full Article (External Site)